{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360869854347142016.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1186/s13195-024-01650-1"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1186/s13195-024-01650-1.pdf"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/article/10.1186/s13195-024-01650-1/fulltext.html"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title>\n          <jats:sec>\n            <jats:title>Background</jats:title>\n            <jats:p>Intracerebral amyloid β (Aβ) accumulation is considered the initial observable event in the pathological process of Alzheimer’s disease (AD). Efficient screening for amyloid pathology is critical for identifying patients for early treatment. This study developed machine learning models to classify positron emission tomography (PET) Aβ-positivity in participants with preclinical and prodromal AD using data accessible to primary care physicians.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Methods</jats:title>\n            <jats:p>This retrospective observational study assessed the classification performance of combinations of demographic characteristics, routine blood test results, and cognitive test scores to classify PET Aβ-positivity using machine learning. Participants with mild cognitive impairment (MCI) or normal cognitive function who visited Oita University Hospital or had participated in the USUKI study and met the study eligibility criteria were included. The primary endpoint was assessment of the classification performance of the presence or absence of intracerebral Aβ accumulation using five machine learning models (i.e., five combinations of variables), each constructed with three classification algorithms, resulting in a total of 15 patterns. L2-regularized logistic regression, and kernel Support Vector Machine (SVM) and Elastic Net algorithms were used to construct the classification models using 34 pre-selected variables (12 demographic characteristics, 11 blood test results, 11 cognitive test results).</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Results</jats:title>\n            <jats:p>Data from 262 records (260 unique participants) were analyzed. The mean (standard deviation [SD]) participant age was 73.8 (7.8) years. Using L2-regularized logistic regression, the mean receiver operating characteristic (ROC) area under the curve (AUC) (SD) in Model 0 (basic demographic characteristics) was 0.67 (0.01). Classification performance was similar in Model 1 (basic demographic characteristics and Mini Mental State Examination [MMSE] subscores) and Model 2 (demographic characteristics and blood test results) with a cross-validated mean ROC AUC (SD) of 0.70 (0.01) for both. Model 3 (demographic characteristics, blood test results, MMSE subscores) and Model 4 (Model 3 and ApoE4 phenotype) showed improved performance with a mean ROC AUC (SD) of 0.73 (0.01) and 0.76 (0.01), respectively. In models using blood test results, thyroid-stimulating hormone and mean corpuscular volume tended to be the largest contributors to classification. Classification performances were similar using the SVM and Elastic Net algorithms.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions</jats:title>\n            <jats:p>The machine learning models used in this study were useful for classifying PET Aβ-positivity using data from routine physician visits.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration</jats:title>\n            <jats:p>UMIN Clinical Trials Registry (UMIN000051776, registered on 31/08/2023).</jats:p>\n          </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420001326219505664","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"30433048"},{"@type":"NRID","@value":"1000030433048"},{"@type":"NRID","@value":"9000285078008"},{"@type":"NRID","@value":"9000414743795"},{"@type":"NRID","@value":"9000411647392"},{"@type":"NRID","@value":"9000410493442"},{"@type":"NRID","@value":"9000017276534"},{"@type":"NRID","@value":"9000258057971"},{"@type":"NRID","@value":"9000411116000"},{"@type":"NRID","@value":"9000002127263"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/N_kimura"}],"foaf:name":[{"@value":"Noriyuki Kimura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380869854347142036","@type":"Researcher","foaf:name":[{"@value":"Kotaro Sasaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380869854347142166","@type":"Researcher","foaf:name":[{"@value":"Teruaki Masuda"}]},{"@id":"https://cir.nii.ac.jp/crid/1380869854347142037","@type":"Researcher","foaf:name":[{"@value":"Takuya Ataka"}]},{"@id":"https://cir.nii.ac.jp/crid/1380869854347142274","@type":"Researcher","foaf:name":[{"@value":"Mariko Matsumoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1380869854347142169","@type":"Researcher","foaf:name":[{"@value":"Mika Kitamura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380869854347142182","@type":"Researcher","foaf:name":[{"@value":"Yosuke Nakamura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380869854347142276","@type":"Researcher","foaf:name":[{"@value":"Etsuro Matsubara"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"17589193"}],"prism:publicationName":[{"@value":"Alzheimer's Research & Therapy"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2025-01-21","prism:volume":"17","prism:number":"1"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["https://creativecommons.org/licenses/by/4.0","https://creativecommons.org/licenses/by/4.0"],"url":[{"@id":"https://link.springer.com/content/pdf/10.1186/s13195-024-01650-1.pdf"},{"@id":"https://link.springer.com/article/10.1186/s13195-024-01650-1/fulltext.html"}],"createdAt":"2025-01-21","modifiedAt":"2025-01-21","project":[{"@id":"https://cir.nii.ac.jp/crid/1040573407560879488","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22K07474"},{"@type":"JGN","@value":"JP22K07474"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K07474/"}],"notation":[{"@language":"ja","@value":"アルツハイマー病におけるNVU障害および神経炎症を基盤とした病態進行機構の解明"},{"@language":"en","@value":"Elucidation of pathological progression mechanism based on NVU dysfunction and neuroinflammation in Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1040858752026734464","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K06911"},{"@type":"JGN","@value":"JP23K06911"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K06911/"}],"notation":[{"@language":"ja","@value":"逆転の発想: 末梢神経障害を起点とした認知症の鑑別診断法確立と至適治療の提供"},{"@language":"en","@value":"Establishment of differential diagnosis and optimal treatment of dementia focusing on peripheral neuropathy"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050287628878675456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer’s Disease by Peptidome Technology"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144665470976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144679029248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145300162176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145308180480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Flotillin: A Promising Biomarker for Alzheimer’s Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146494015360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171889155968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Neurovascular Unit Dysfunction in Alzheimer’s Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021391865396736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021397010812288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention"}]},{"@id":"https://cir.nii.ac.jp/crid/1360023717382154624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025434936877696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prevalence Rates of Amyloid Positivity—Updates and Relevance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025434936885888","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025434939024384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-β Levels in Alzheimer’s Disease: The Chongqing Ageing & Dementia Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025439250779776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025439394752512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617848638464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of Modifiable Lifestyle Factors With Cortical Amyloid Burden and Cerebral Glucose Metabolism in Older Adults With Mild Cognitive Impairment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298343438622976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302870464986752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871314765312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Accurate risk estimation of β‐amyloid positivity to identify prodromal Alzheimer's disease: Cross‐validation study of practical algorithms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871315353472","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Thyroid Hormone Negatively Regulates the Transcriptional Activity of the β-Amyloid Precursor Protein Gene"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871495561344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905181448832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306912229830272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 participants"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306913639727232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Associations of Blood and Cerebrospinal Fluid Aβ and tau Levels with Renal Function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306913641167488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Subject classification and cross-time prediction based on functional connectivity and white matter microstructure features in a rat model of Alzheimer’s using machine learning"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306913641397504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Association Between Thyroid Diseases and Alzheimer’s Disease in a National Health Screening Cohort in Korea"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182193464960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093931215744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094207847936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095788805504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hemoglobin level in older persons and incident Alzheimer disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579820495992704","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"2022 Alzheimer's disease facts and figures"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580236938712064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580236951514368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360581631009464320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360581634782700672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Blood Biomarkers in Neurodegenerative Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340714457856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Predicting positron emission tomography brain amyloid positivity using interpretable machine learning models with wearable sensor data and lifestyle factors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343252271616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Coronary risk correlates with cerebral amyloid deposition"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343737764096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231"}]},{"@id":"https://cir.nii.ac.jp/crid/1360587983619781888","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lecanemab: First Approval"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588383693836544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588387234445696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588389192803328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588389212216192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Machine Learning Approach for Early Diagnosis of Cognitive Impairment Using Population-Based Data"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857597058295168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857597257412224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels—Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857762413306496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861713875184256","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Science and Practice of Micronutrient Supplementations in Nutritional Anemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865819391829120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869858934962688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869859932612736","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The accuracy and robustness of plasma biomarker models for amyloid PET positivity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869859996707584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Is Alzheimer’s Disease a Liver Disease of the Brain?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869861242116352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Blood Hemoglobin, in-vivo Alzheimer Pathologies, and Cognitive Impairment: A Cross-Sectional Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869862205142272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869864671620608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Alzheimer amyloid β‐peptides exhibit ionophore‐like properties in human erythrocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869864671969408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The cross-sectional association between mean corpuscular volume level and cognitive function in Chinese over 45 years old: Evidence from the China Health and Retirement Longitudinal Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131644069857024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Flotillin is a Novel Diagnostic Blood Marker of Alzheimer’s Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994375185792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Changes in Phospholipid Composition of Erythrocyte Membrane in Alzheimer’s Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995417655552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469493959808","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420191146368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Age, APOE and sex: Triad of risk of Alzheimer’s disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894526435072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368899241984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369541473536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Plasma Amyloid as Prescreener for the Earliest <scp>A</scp>lzheimer Pathological Changes"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370335712640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370440068224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107371204686720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363383443982813568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Modifiable Lifestyle Factors and Cognitive Function in Older People: A Cross-Sectional Observational Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843258083456","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844121086976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269943368960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Feature Selection with the<b>Boruta</b>Package"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270164196992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Dementia prevention, intervention, and care"}]},{"@id":"https://cir.nii.ac.jp/crid/1370869854347142146","@type":"Product","relationType":["references"]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1186/s13195-024-01650-1"},{"@type":"KAKEN","@value":"PRODUCT-25722266"},{"@type":"KAKEN","@value":"PRODUCT-25523470"}]}